Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-211-0 | CAS number: 117-81-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Respiratory sensitisation
Administrative data
- Endpoint:
- respiratory sensitisation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test procedure in accordance with generally accepted scientific standards, described in sufficiently detailled.
Data source
Reference
- Reference Type:
- publication
- Title:
- Phthalate treatment does not influence levels of IgE or Th2 cytokines in B6C3F1 mice
- Author:
- Butala JH, David RM, Gansc G
- Year:
- 2 004
- Bibliographic source:
- Toxicology 201 (2004) 77–85
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- topical application (and challenge) of test substances to mice followed by measurements of serum IgE.
auricular lymph nodes harvesting for measurement of IL-4 and IL-13 proteins and their corresponding mRNAs.
liver weight increase monitoring (for evaluation of skin absorption). - GLP compliance:
- not specified
Test material
- Reference substance name:
- Bis(2-ethylhexyl) phthalate
- EC Number:
- 204-211-0
- EC Name:
- Bis(2-ethylhexyl) phthalate
- Cas Number:
- 117-81-7
- Molecular formula:
- C24H38O4
- IUPAC Name:
- 1,2-bis(2-ethylhexyl) benzene-1,2-dicarboxylate
- Details on test material:
- - Name of test material (as cited in study report): di(2-ethylhexyl)phthalate DEHP
- Physical state: liquid
- Analytical purity: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: no data
- Weight at study initiation: no data
- Housing: no data
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
"in accordance with regulatory guidelines (NRC, 1996)"
Test system
- Route of induction exposure:
- dermal
- Route of challenge exposure:
- other: dermal (on the ears)
- Vehicle:
- unchanged (no vehicle)
- Concentration:
- 0, 25, 50, 100 %
- No. of animals per dose:
- positive and negative control groups: 10 females per dose
tests groups:15 females per dose - Details on study design:
- A. INDUCTION EXPOSURE
- No. of exposures: 10
- Exposure period: 6 hours / exposure
The application sites for animals given test or positive control substances were covered with fiber pads and semi-occlusive wraps to maintain skin contact and to prevent the mice from licking the treated areas. After 6 hours the wrappings were removed, and the treated areas were cleaned.
- Site: on each flank in 50µl aliquots
- Frequency of applications: once daily
- Duration: 6 hours/day, 5 days/week for 2 weeks
- Concentrations: 0, 25, 50, 100%
- Evaluation: Five mice were taken at the end of the induction period for assessment of liver weights.
B. CHALLENGE EXPOSURE
- No. of exposures: 1 exposure
- Day(s) of challenge: Day 21
Challenge doses of test or control substances were applied in 25 ml aliquots to the ears of the each of the remaining mice except for the untreated control animals that were not treated in either the induction or the challenge phases.
- Site: ear
- Concentrations: 0, 25, 50, 100%
- Evaluation: After an additional week without treatment, the remaining mice were euthanized. Blood samples and auricular lymph nodes were removed for IgE, IL-4, and IL-13 assessments. - Challenge controls:
- none
- Positive control substance(s):
- trimellitic anhydride (TMA)
- Negative control substance(s):
- 2,4-dinitrochlorobenzene (DNCB)
Results and discussion
- Results:
- All animals survived.
No significant differences in body weight was observed.
Liver weights of DEHP-treated mice were significantly elevated with respect to control.
Phthalate treatment had no effect on IL-4 or IL-13 mRNA levels. - Positive control results:
- Serum IgE levels were significantly increased by treatment with the positive control, TMA.
TMA increased IL-4 and IL-13 mRNAs in lymph node cells. The assessment of IL-4 and IL-13 levels in cultured lymph node cells revealed a large and statistically significant increase in cells from mice treated with TMA. - Negative control results:
- A small but still significant increase of serum IgE level has been observed in mice treated with DNCB, a contact sensitizer.
IL-4 and IL-13 levels were also elevated in the DNCB-treated groups in most situations but were not significantly different from control values. Neither IL-4 nor IL-13 was elevated in cells from control group mice or mice treated with any of the phthalates.
DNCB treatment increased IL-4 and IL-13 mRNA, but these differences, although statistically significant, were well below levels associated with TMA treatment.
The appropriate responses with the reference compounds demonstrated the specificity of the assay system.
Any other information on results incl. tables
Dose Group |
Body Weight (g) |
Liver Weight (g) |
% of Body Weight |
Vehicle control |
16.57 + 1.14 |
0.816 + 0.079 |
4.94 + 0.56 |
DEHP (25%) |
16.34 + 0.60 |
0.984 + 0.044* |
6.02 + 0.31* |
DEHP (50%) |
16.04 + 0.72 |
1.109 + 0.030* |
6.92 + 0.20* |
DEHP (100%) |
16.70 + 1.16 |
1.349 + 0.178* |
8.05 + 0.56* |
* Values significantly different from control (* = P0.05) are indicated by an asterisk.
Table 4: Total Serum IgE levels in female B6C3F1 mice exposed to DEHP for 14 days.
Administered Material |
Total IgE (mg/ml) |
Challenge Control |
0.69 + 0.19 (10)1 |
Vehicle Control |
0.74 + 0.08 (10) |
TMA (respiratory sensitizer) 25% |
6.34 + 1.00** (10) |
DNCB (contact sensitizer) 1% |
1.76 + 0.32** (10) |
DEHP (undiluted) |
0.86 + 0.10 (10) |
DEHP (50%) |
0.89 + 0.12 (10) |
DEHP (25 %) |
0.60 + 0.05 (10) |
+ SE. The number of animals used in each test is given in parentheses. Values significantly different from vehicle control are noted by an asterisk, ** = p 0.01
Table 5: IL-4 and IL-13 concentrations from Con A-stimulated, cultured lymph node cells from female B6C3F1 mice exposed to DEHP for 14 days.
Administered Material |
Total IL-4 concentration (pg/ml) |
Total IL-13 concentration (pg/ml) |
Assay Controls |
||
Untreated Control |
2.73 + 0.48 (5) 1 |
5.35 + 1.44 (5) |
Vehicle Control |
2.73 + 0.48 (5) |
3.91 + 0.00 (5) |
TMA (respiratory sensitizer) 25% |
20.38 + 3.81 **(5) |
30.61 + 6.82 **2 (5) |
DNCB (contact sensitizer) 1% |
2.73 + 0.48 (5) |
5.07 + 1.16 (5) |
Test Substance Evaluation |
||
DEHP (undiluted) |
2.34 + 0.39 (5) |
3.91 + 0.00 (5) |
DEHP (50% in vehicle) |
2.930+ 0.57 (4) 3 |
3.91 + 0.00 (4)3 |
DEHP (25 % in vehicle) |
2.44 + 0.49 (4) 3 |
3.91 + 0.00 (4)3 |
Values represent the mean + SE derived from the number of cultures indicated in parentheses. The lower limit of IL-4 detection was 3.91 pg/ml. Statistical significance is indicated by asterisks (** = p 0.05).
Table 6: IL-4 and IL-13 mRNA concentrations from Con A-stimulated, cultured lymph node cells from female B6C3F1 mice exposed to DEHP for 14 days.
Administered Material |
Total IL-4 mRNA concentration (pg/ml) |
Total IL-13 mRNA concentration (pg/ml) |
Untreated Controls |
||
Untreated Control |
2.4 + 1.6 (5)1 |
4.6 + 2.9 (5) |
Vehicle Control |
0.0 + 0.0 (5) |
2.0 + 1.2 (5) |
TMA (respiratory sensitizer) 25% |
31.4 + 5.14 (5) |
40.8 + 6.1** (5) |
DNCB (contact sensitizer) 1% |
1.6 + 1.6 (5) |
3.4 + 2.9 (5) |
Test Substance Evaluation |
||
DEHP (undiluted) |
0.0 + 0.0 (5) |
0.0 + 0.0 (5) |
DEHP (50% in vehicle) |
0.0 + 0.0 (4) 2 |
1.8 + 1.8 (4) |
DEHP (10 % in vehicle) |
0.0 + 0.0 (4) 2 |
0.0 + 0.0 (4) |
1 Unless otherwise indicated, each culture was prepared from pooled lymph nodes from 2 animals. Values represent the mean +SE derived from the number of cultures indicated in parentheses. The lower limit of IL-4 detection was 3.906 pg/ml.
2 Values represent 3 cultures obtained from pooling of nodes obtained from 2 animals and 1 culture from pooling of nodes obtained from 4 animals.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Conclusions:
- Under these experimental conditions, DEHP is not considered as a respiratory sensitizer.
- Executive summary:
Di(2-ethylhexyl) phthalate (DEHP) was tested using for respiratory sensitization in B6C3F1 mice. This test involves topical application and challenge of DEHP to mice followed by measurements of serum IgE.
In addition auricular lymph nodes were harvested for measurement of IL-4 and IL-13 proteins and their corresponding messenger RNAs. Liver weight increase, a measure of peroxisomal proliferation, was monitored to assure that internal dosing had been achieved.
ELISA and RNAse protection assays demonstrated that DEHP treatment did not significantly affect IgE, IL-4 or IL-13 levels. Similarly IL-4 and IL-13 mRNA levels were not elevated. In contrast, all of these were significantly elevated by trimellitic anhydride (TMA), a respiratory sensitizer used as the positive control in this assay. Liver weights were significantly elevated by DEHP, providing evidence of sufficient percutaneous absorption to induce physiological responses.
Under these experimental conditions, DEHP is not considered as a respiratory sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.